Pharmaceutical Development Specialist

GENEL NİTELİKLER VE İŞ TANIMI

Abdi İbrahim, founded in 1912, has the largest product portfolio in the sector and is the largest employer in the Turkish pharmaceutical industry with 5.500 employees. Abdi İbrahim has been the leader of Turkey’s pharmaceutical industry since 2002 with its powerful vision.

Today, Abdi İbrahim operates in 17 countries outside Türkiye, exports to more than 70 countries ranging from Canada to European Union member states, from North Africa to Asia. As a corporate citizen working towards creating a better world and a better future, adhering to its mission in the sector and to the requirements of societal priorities, Abdi İbrahim focuses on sustainability in all its business processes.

Its vision for 2025 - apart from maintaining its status as a wholly local company - is to become "one of the top 100 pharmaceutical companies in the world.

We are looking for an " Pharmaceutical Development Specialist " to join our R&D Center located in Esenyurt.

Qualifications

• Bachelor’s degree in Pharmacy, Chemistry, or Chemical Engineering; a Master’s degree in a related field is preferred,
• 3–5 years of experience in formulation development within R&D galenic laboratories,
• Experience in solid dosage form production processes such as tablet compression, capsule filling, film coating, granulation, and semi-solid manufacturing,
• Knowledgeable and experienced in the use of laboratory and production equipment,
• Proficient in English (written and spoken), with the ability to follow current publications and regulatory guidelines,
• Strong team player with good communication and organizational skills.

Job Description

• Conduct patent and literature research for assigned projects,
• Execute pre-formulation studies and determine the final formulation by monitoring parameters that best represent similarity to the reference product,
• Perform compatibility studies for raw materials included in the finalized formulation,
• Prepare process validation/evaluation reports and draft the relevant sections of the regulatory dossier.